{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2015, Part 2

Activity Steps

Purpose of Activity

To provide an overview of eight drugs recently approved by the FDA.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify indications for eight new drugs.
  2. Identify adverse reactions associated with eight new drugs.
  3. Identify nursing considerations related to eight new drugs.
Price: $27.95


  • ANCC 3.0 CH / 3.0 APH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH
  • GA - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours

Test Code: N0715B
Published: Jul 2015
Expires: 6/5/2020
Sources: Nursing2020
Passing Score: 13/18 (72%)
Authors: Daniel A. Hussar, PhD
Specialties: Diabetes, Primary Care